The Steele Group was thrilled to partner with Anagenex for their site selection and expansion to 20 Maguire Road in Lexington MA. This turnkey move unlocked a new phase of growth and development for the company.

Anagenex is a pioneering drug discovery company that combines large-scale data generation with machine learning to discover the next generation of small molecule medicines. Anagenex has stalwart investors such as Catalio Capital Management, Lux Capital, Khosla Ventures, Obvious Ventures, Air Street Capital, and Menlo Ventures. The team will continue to further develop Anagenex’s innovative data generation platform and to build a robust pipeline of programs aimed at addressing historically challenging unmet medical needs. By integrating advanced data generation techniques with machine learning, Anagenex aims to revolutionize the discovery and development of small molecule drugs, offering new solutions to complex medical challenges.